Market open

Liquidia/LQDA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Liquidia

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Ticker

LQDA
Trading on

Industry

Pharmaceuticals

Employees

145

Liquidia Metrics

BasicAdvanced
$940M
Market cap
-
P/E ratio
-$1.59
EPS
0.32
Beta
-
Dividend rate
$940M
0.32
$16.99
$5.71
1M
6.08
5.629
133.111
141.687
-11.00%
-40.69%
-181.73%
52.966
13.57
15.33
-8.966
-16.65%
102.01%
27.26%
13.70%

What the Analysts think about Liquidia

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Liquidia stock.

Liquidia Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Liquidia Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy LQDA

$

Sign up or log in to buy
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Liquidia stock?

Liquidia (LQDA) has a market cap of $940M as of October 15, 2024.

What is the P/E ratio for Liquidia stock?

The price to earnings (P/E) ratio for Liquidia (LQDA) stock is 0 as of October 15, 2024.

Does Liquidia stock pay dividends?

No, Liquidia (LQDA) stock does not pay dividends to its shareholders as of October 15, 2024.

When is the next Liquidia dividend payment date?

Liquidia (LQDA) stock does not pay dividends to its shareholders.

What is the beta indicator for Liquidia?

Liquidia (LQDA) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.